Wells Fargo’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$252K Sell
763,114
-23,433
-3% -$7.73K ﹤0.01% 4251
2025
Q1
$245K Buy
786,547
+42,740
+6% +$13.3K ﹤0.01% 4117
2024
Q4
$694K Buy
743,807
+8,622
+1% +$8.05K ﹤0.01% 3508
2024
Q3
$868K Sell
735,185
-6,455
-0.9% -$7.62K ﹤0.01% 3293
2024
Q2
$570K Buy
741,640
+307,768
+71% +$237K ﹤0.01% 3498
2024
Q1
$1.32M Sell
433,872
-14,719
-3% -$44.9K ﹤0.01% 2959
2023
Q4
$1.44M Buy
448,591
+3,625
+0.8% +$11.7K ﹤0.01% 2864
2023
Q3
$1.71M Sell
444,966
-6,001
-1% -$23K ﹤0.01% 2715
2023
Q2
$1.48M Buy
450,967
+20,306
+5% +$66.6K ﹤0.01% 2985
2023
Q1
$1.11M Buy
430,661
+1,505
+0.4% +$3.88K ﹤0.01% 3089
2022
Q4
$798K Sell
429,156
-5,664
-1% -$10.5K ﹤0.01% 3171
2022
Q3
$800K Buy
434,820
+2,819
+0.7% +$5.19K ﹤0.01% 3175
2022
Q2
$929K Sell
432,001
-2,852
-0.7% -$6.13K ﹤0.01% 3147
2022
Q1
$1.37M Sell
434,853
-17,514
-4% -$55K ﹤0.01% 3414
2021
Q4
$1.45M Sell
452,367
-1,750
-0.4% -$5.62K ﹤0.01% 3563
2021
Q3
$1.53M Buy
454,117
+500
+0.1% +$1.68K ﹤0.01% 3700
2021
Q2
$1.77M Sell
453,617
-4,668
-1% -$18.3K ﹤0.01% 3596
2021
Q1
$1.84M Sell
458,285
-93,474
-17% -$376K ﹤0.01% 3549
2020
Q4
$1.27M Buy
551,759
+16,673
+3% +$38.5K ﹤0.01% 3784
2020
Q3
$3.07M Buy
535,086
+14,651
+3% +$84.1K ﹤0.01% 2931
2020
Q2
$3.84M Buy
520,435
+30,614
+6% +$226K ﹤0.01% 2702
2020
Q1
$1.46M Buy
489,821
+16,188
+3% +$48.3K ﹤0.01% 3183
2019
Q4
$1.97M Buy
473,633
+51,933
+12% +$216K ﹤0.01% 3326
2019
Q3
$1.37M Sell
421,700
-20,904
-5% -$67.7K ﹤0.01% 3573
2019
Q2
$819K Buy
442,604
+128,618
+41% +$238K ﹤0.01% 3946
2019
Q1
$556K Buy
313,986
+307,087
+4,451% +$544K ﹤0.01% 4221
2018
Q4
$17K Sell
6,899
-48
-0.7% -$118 ﹤0.01% 5464
2018
Q3
$39K Buy
6,947
+433
+7% +$2.43K ﹤0.01% 5359
2018
Q2
$51K Sell
6,514
-324
-5% -$2.54K ﹤0.01% 5319
2018
Q1
$48K Buy
6,838
+6,053
+771% +$42.5K ﹤0.01% 5283
2017
Q4
$8K Buy
785
+433
+123% +$4.41K ﹤0.01% 5579
2017
Q3
$3K Buy
+352
New +$3K ﹤0.01% 5705